A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor
Clinical trial NCT01874665 · COMPLETED
Trial details
- NCT number
- NCT01874665
- Sponsor
- Ariad Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-05
- Primary completion
- 2015-02-28
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.